C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 405/12 (2006.01) A61K 31/4406 (2006.01) A61K 31/443 (2006.01) A61K 31/4545 (2006.01) A61P 9/10 (2006.01) A61P 27/02 (2006.01) A61P 41/00 (2006.01) C07D 401/12 (2006.01)
Patent
CA 2192092
Compounds of formula (I) wherein R, R1, R2 and Ar are as defined in the specification, have valuable pharmaceutical properties and are effective especially as matrix metalloproteinase inhibitors, for example for the treatment of arthritis. They are prepared in a manner known per se.
L'invention se rapporte à des composés de la formule (I) dans laquelle R, R1, R2 et Ar sont tels que définis dans la demande. Ces composés ont de précieuses propriétés pharmaceutiques et sont notamment efficaces comme inhibiteurs de métalloprotéinases matricielles, par exemple, dans le traitement de l'arthrite. Ils sont préparés d'une manière connue en soi.
Jeng Arco Yingcheu
Macpherson Lawrence Joseph
Parker David Thomas
Ag Ciba-Geigy
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Arylsulfonamido-substituted hydroxamic acids as matrix... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylsulfonamido-substituted hydroxamic acids as matrix..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonamido-substituted hydroxamic acids as matrix... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1617641